Tapewire

NYSE · USD

TDOC

Teladoc Health, Inc.

Export transactions ↓
Tapewire entity
1547
SEC CIK
0001477449
Parsed reports
839

Last 12 months

Inside the activity.

1 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202506
Jan 202601
Feb 202600
Mar 202608
Apr 202601
May 202600
Jun 202609
Jul 202603
Aug 202600
Sep 202608
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 06, 2024 Filed Aug 8, 2024 17:49 UTC PurchaseCommon Stock 7,000 $7.57 $52,990.00
Disclosure

SEC source: 0001628280-24-036269 · wk-form4_1723153776.xml · nonDerivative · entry 1

MCKINLEY THOMAS · CIK 0001041117 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,077

Read SEC document
August 05, 2024 Filed Aug 6, 2024 22:10 UTC
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
SaleCommon Stock 1,537 $7.33 $11,266.21
Disclosure

SEC source: 0001628280-24-035293 · wk-form4_1722982245.xml · nonDerivative · entry 1

Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,130

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 21:01 UTC
Waters Michael WillemCHIEF OPERATING OFFICER
SaleCommon Stock 6,053 $8.14 $49,283.53
Disclosure

SEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · nonDerivative · entry 2

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,214

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 20:59 UTC
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
SaleCommon Stock 3,857 $8.14 $31,403.69
Disclosure

SEC source: 0001628280-24-034804 · wk-form4_1722891553.xml · nonDerivative · entry 2

Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,667

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 20:56 UTC
Kornwasser LaizerAdvisor to the CEO
SaleCommon Stock 10,879 $8.14 $88,576.82
Disclosure

SEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · nonDerivative · entry 2

Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,929

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 21:01 UTC
Waters Michael WillemCHIEF OPERATING OFFICER
Exercise / conversionRestricted Stock Units · Derivative 11,319 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · derivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,280

Underlying: Common Stock · 11,319 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On August 1, 2022, the reporting person was granted 135,833 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 21:01 UTC
Waters Michael WillemCHIEF OPERATING OFFICER
Exercise / conversionCommon Stock 11,319 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-034809 · wk-form4_1722891689.xml · nonDerivative · entry 1

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 80,267

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:59 UTC
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
Exercise / conversionRestricted Stock Units · Derivative 10,244 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-034804 · wk-form4_1722891553.xml · derivative · entry 3

Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,732

Underlying: Common Stock · 10,244 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On May 1, 2022, the reporting person was granted 122,927 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:59 UTC
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
Exercise / conversionCommon Stock 10,244 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-034804 · wk-form4_1722891553.xml · nonDerivative · entry 1

Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,524

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:56 UTC
Kornwasser LaizerAdvisor to the CEO
Exercise / conversionRestricted Stock Units · Derivative 20,198 $0.00 $0.00
Disclosure

SEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · derivative · entry 3

Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,994

Underlying: Common Stock · 20,198 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On November 1, 2022, the reporting person was granted 242,382 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 20:56 UTC
Kornwasser LaizerAdvisor to the CEO
Exercise / conversionCommon Stock 20,198 Not disclosed Not disclosed
Disclosure

SEC source: 0001628280-24-034799 · wk-form4_1722891396.xml · nonDerivative · entry 1

Kornwasser Laizer · CIK 0001387813 · Advisor to the CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,808

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
July 02, 2024 Filed Jul 2, 2024 17:00 UTC
Nanis Nikolaos P.Chief Technology Officer
SaleCommon Stock 442 $9.39 $4,150.38
Disclosure

SEC source: 0001477449-24-000166 · wk-form4_1719954009.xml · nonDerivative · entry 2

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,226

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 17:00 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionRestricted Stock Units · Derivative 1,233 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000166 · wk-form4_1719954009.xml · derivative · entry 3

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,165

Underlying: Common Stock · 1,233 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On October 1, 2022, the reporting person was granted 14,793 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 17:00 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionCommon Stock 1,233 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000166 · wk-form4_1719954009.xml · nonDerivative · entry 1

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,668

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
June 10, 2024 Filed Jun 12, 2024 20:05 UTC
DIVITA CHARLES IIIDirector · CHIEF EXECUTIVE OFFICER
GrantRestricted Stock Units · Derivative 469,924 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000161 · wk-form4_1718222734.xml · derivative · entry 1

DIVITA CHARLES III · CIK 0001347535 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 469,924

Underlying: Common Stock · 469,924 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.

F2 · derivative.exercise_date: One-third of the restricted stock units vest on June 10, 2025, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F2 · derivative.expiration_date: One-third of the restricted stock units vest on June 10, 2025, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
June 04, 2024 Filed Jun 4, 2024 20:06 UTC
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
SaleCommon Stock 468 $11.04 $5,166.72
Disclosure

SEC source: 0001477449-24-000150 · wk-form4_1717531567.xml · nonDerivative · entry 5

Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,280

F3 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 1, 2024.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
SaleCommon Stock 854 $11.16 $9,528.08
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 5

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,479

F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
SaleCommon Stock 1,040 $11.16 $11,603.28
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 5

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,435

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
SaleCommon Stock 1,627 $11.16 $18,152.44
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 4

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,659

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 16:05 UTC
Verstraete StephanyCHIEF MARKETING OFFICER
SaleCommon Stock 2,096 $11.16 $23,385.07
Disclosure

SEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · nonDerivative · entry 4

Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,158

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:07 UTC
Murthy MalaACTING CEO, CFO
SaleCommon Stock 8,807 $11.16 $98,259.70
Disclosure

SEC source: 0001477449-24-000155 · wk-form4_1717531636.xml · nonDerivative · entry 5

Murthy Mala · CIK 0001780955 · ACTING CEO, CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 78,713

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:07 UTC
Geshuri ArnnonCHIEF PEOPLE OFFICER
SaleCommon Stock 1,807 $11.16 $20,160.70
Disclosure

SEC source: 0001477449-24-000154 · wk-form4_1717531620.xml · nonDerivative · entry 4

Geshuri Arnnon · CIK 0001830520 · CHIEF PEOPLE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,686

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:06 UTC
Waters Michael WillemCHIEF OPERATING OFFICER
SaleCommon Stock 4,246 $11.16 $47,372.62
Disclosure

SEC source: 0001477449-24-000152 · wk-form4_1717531594.xml · nonDerivative · entry 3

Waters Michael Willem · CIK 0001936444 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,948

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:06 UTC
Kornwasser LaizerPRESIDENT, ENTERPRISE GROWTH
SaleCommon Stock 4,812 $11.16 $53,687.48
Disclosure

SEC source: 0001477449-24-000151 · wk-form4_1717531580.xml · nonDerivative · entry 3

Kornwasser Laizer · CIK 0001387813 · PRESIDENT, ENTERPRISE GROWTH

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,610

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:06 UTC
Raman-Tangella VidyaCHIEF MEDICAL OFFICER
SaleCommon Stock 1,122 $11.16 $12,518.15
Disclosure

SEC source: 0001477449-24-000150 · wk-form4_1717531567.xml · nonDerivative · entry 4

Raman-Tangella Vidya · CIK 0001918441 · CHIEF MEDICAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,748

F4 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:06 UTC
Trencher DanielCHIEF STRATEGY OFFICER
SaleCommon Stock 1,790 $11.16 $19,971.03
Disclosure

SEC source: 0001477449-24-000149 · wk-form4_1717531555.xml · nonDerivative · entry 4

Trencher Daniel · CIK 0001830122 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,322

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
June 03, 2024 Filed Jun 4, 2024 20:05 UTC
Vandervoort Adam CCHIEF LEGAL OFFICER, SECRETARY
SaleCommon Stock 4,015 $11.16 $44,795.36
Disclosure

SEC source: 0001477449-24-000145 · wk-form4_1717531502.xml · nonDerivative · entry 4

Vandervoort Adam C · CIK 0001375088 · CHIEF LEGAL OFFICER, SECRETARY

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,264

F3 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionRestricted Stock Units · Derivative 1,162 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 9

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,139

Underlying: Common Stock · 1,162 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 13,951 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionRestricted Stock Units · Derivative 383 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 8

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,534

Underlying: Common Stock · 383 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 4,598 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionRestricted Stock Units · Derivative 1,001 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 7

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,001 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date.

F4 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 4,002 restricted stock units, vesting in four substantially equal semiannual installments beginning on the six-month anniversary of the grant date.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionRestricted Stock Units · Derivative 339 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · derivative · entry 6

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,017

Underlying: Common Stock · 339 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F3 · derivative.exercise_date: On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F3 · derivative.expiration_date: On April 1, 2022, the reporting person was granted 4,067 restricted stock units, vesting one-third on March 1, 2023, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionCommon Stock 1,162 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 4

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionCommon Stock 383 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 3

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionCommon Stock 1,001 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 2

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,788

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Cave James L.INTERIM CAO
Exercise / conversionCommon Stock 339 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000147 · wk-form4_1717531528.xml · nonDerivative · entry 1

Cave James L. · CIK 0002019394 · INTERIM CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,787

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionRestricted Stock Units · Derivative 1,085 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 9

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,596

Underlying: Common Stock · 1,085 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F7 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F7 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionRestricted Stock Units · Derivative 894 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 8

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,578

Underlying: Common Stock · 894 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F6 · derivative.exercise_date: On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionRestricted Stock Units · Derivative 505 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 7

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,518

Underlying: Common Stock · 505 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionPerformance Stock Units · Derivative 370 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · derivative · entry 6

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,588

Underlying: Common Stock · 370 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionCommon Stock 1,085 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 4

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,475

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionCommon Stock 894 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 3

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionCommon Stock 505 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 2

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,496

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Nanis Nikolaos P.Chief Technology Officer
Exercise / conversionCommon Stock 370 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000146 · wk-form4_1717531514.xml · nonDerivative · entry 1

Nanis Nikolaos P. · CIK 0002001935 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,991

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
Exercise / conversionRestricted Stock Units · Derivative 3,100 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 7

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,702

Underlying: Common Stock · 3,100 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 37,202 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
Exercise / conversionRestricted Stock Units · Derivative 1,348 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 6

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,044

Underlying: Common Stock · 1,348 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F5 · derivative.exercise_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F5 · derivative.expiration_date: On March 1, 2022, the reporting person was granted 16,170 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
Exercise / conversionPerformance Stock Units · Derivative 1,056 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · derivative · entry 5

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,397

Underlying: Common Stock · 1,056 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

F4 · derivative.exercise_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F4 · derivative.expiration_date: On March 1, 2024, the reporting person earned 12,679 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
Exercise / conversionCommon Stock 3,100 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 3

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,286

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
Exercise / conversionCommon Stock 1,348 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 2

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,186

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:06 UTC
Turitz AndrewEVP, CORPORATE DEVELOPMENT
Exercise / conversionCommon Stock 1,056 Not disclosed Not disclosed
Disclosure

SEC source: 0001477449-24-000153 · wk-form4_1717531608.xml · nonDerivative · entry 1

Turitz Andrew · CIK 0001726221 · EVP, CORPORATE DEVELOPMENT

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,838

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Performance stock units convert to shares of TDOC common stock on a one-for-one basis.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 16:05 UTC
Verstraete StephanyCHIEF MARKETING OFFICER
Exercise / conversionRestricted Stock Units · Derivative 3,255 $0.00 $0.00
Disclosure

SEC source: 0001477449-24-000148 · wk-form4_1717531541.xml · derivative · entry 7

Verstraete Stephany · CIK 0001726419 · CHIEF MARKETING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,787

Underlying: Common Stock · 3,255 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.

F6 · derivative.exercise_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

F6 · derivative.expiration_date: On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.